Small Molecules
21 July 2015
Merck Receives EU-Approval to Extend Kuvan Use to Children with PKU Below 4 Years of Age17 July 2015
Galderma Receives FDA Approval for New Antibiotic-Free Treatment Option for Acne Patients15 July 2015
Enteris BioPharma Oral Formulation Progresses Into Phase 2 Study With Cara Therapeutics’ CR84515 July 2015
Takeda Submits New Drug Application for Ixazomib for Patients with Relapsed/Refractory Multiple Myeloma14 July 2015
BeiGene Doses First Patient in Phase Ib Study of BGB-283, a Novel Second Generation B-RAF Inhibitor14 July 2015
Cytokinetics Announces Start of Phase 3 Clinical Trial of Tirasemtiv in Patients With ALS14 July 2015
Licensing Agreement for Agent Targeting Prevention of Recurrence of Hepatocellular Carcinoma “Peretinoin”14 July 2015
Blueprint Medicines Receives FDA Authorization to Proceed with Clinical Trials for Two Drug CandidatesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports